
GRFS vs MLYS
$GRFS vs $MLYS head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
GRFS vs MLYS: the quick read
- ·MLYS is the larger company by market cap ($1.98B vs $1.94B).
- ·MLYS has been more active on our scanner (110 vs 29 alerts in 30 days).
- ·MLYS has the smaller float (66.8M vs 680.6M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (Pharmaceutical Preparations vs PHARMACEUTICAL PREPARATIONS), so they answer to different catalysts and a move in one says little about the other.
- ·MLYS draws far more of our scanner's attention, 110 unusual-volume alerts in 30 days against 29, so it is the more actively traded of the two by some distance.
- ·They are closely matched in size, within 2% of each other on market cap, which makes the rest of this table the interesting part.
- ·Both sit in the bottom quarter of their 52-week range, so this is a comparison of two names well off their highs.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing GRFS and MLYS on TheDesperateTrader.
- Is GRFS or MLYS the better stock?
- "Better" depends on your goal, and these two are not alike. MLYS is the larger company by market cap ($1.98B vs $1.94B). MLYS has been more active on our scanner (110 vs 29 alerts in 30 days). MLYS has the smaller float (66.8M vs 680.6M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between GRFS and MLYS?
- The differences that matter: they are not in the same business - GRFS is pharmaceutical preparations and MLYS is pharmaceutical preparations; they are similar in size ($1.94B vs $1.98B); they trade at very different share prices ($7.48 vs $22.35); GRFS sits at 18% of its 52-week range against 3% for MLYS; our scanner flagged GRFS 29 times in the last 30 days against 110 for MLYS. Everything above is measured from the latest completed session and SEC filings.
- Which of GRFS and MLYS is more active right now?
- Right now GRFS is at about 0.6x its normal volume and MLYS is at about 1.7x, so MLYS is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading GRFS or MLYS? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore GRFS and MLYS comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.